Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Alert follows 40 reports of pregnancy in women taking these weight-loss drugs such as Ozempic, Wegovy, and Mounjaro ...